Last updated on September 2017

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer


Brief description of study

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

Detailed Study Description

A Phase III Randomized Placebo-Controlled Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Stage III Colon Cancer

For Study Locations, Click Here

Clinical Study Identifier: TX153182

Contact Investigators or Research Sites near you

Start Over

Research Center

Research Center
Additional Locations, IN USA
  Connect »

Research Center

Research Center
Additional Locations, IO USA
  Connect »